

Nikos Vasilakis
924 posts

@Vasilakis_Lab
Our focus is to understand the mechanisms that allow zoonotic, sylvatic arthropod-borne viruses to jump species boundaries and cause disease. Shared lab account



Maternal dengue antibodies can have two effects in infants: early protection, followed by increased risk of severe disease between 5–12 months (antibody-dependent enhancement). In Brazil dengue rose sharply from 2000–2024, with peaks of severe risk at birth and around 7–8 months.




Intra-host population dynamics of chikungunya virus in humans and naturally infected Aedes mosquitoes reveal transmission-driven diversity academic.oup.com/ve/article/doi… just published! @ACAV_ASTMH @AgenciaFAPESP @famerp @Vasilakis_Lab


















